Skip to main content

Year: 2021

Immuneering Reports Third Quarter 2021 Financial Results and Recent Business Highlights

Successfully completed upsized initial public offering raising $129.4 million in gross proceeds, providing runway into 2024 Company expects to file IND for IMM-1-104 in Q1 2022 CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics, today reported financial results for the third quarter ended September 30, 2021 and provided recent business highlights. “We made notable progress in the third quarter, including completing our IPO, and are well-funded to support the continued development of our robust pipeline of oncology and neuroscience drug programs. In the near term, we anticipate filing our Investigational New Drug (IND) application...

Continue reading

Progenity Appoints Adi Mohanty as Chief Executive Officer

SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Adi Mohanty as Chief Executive Officer of the company, effective November 8, 2021. Mr. Mohanty also joins the Progenity Board of Directors. “As we complete the execution of our strategic transformation, we are continuing to build biotechnology and biotherapeutics leadership capabilities to help ensure our success,” said Eric d’Esparbes, Chief Financial Officer and interim CEO. “To this end, we are delighted to welcome Adi Mohanty to Progenity as Chief Executive Officer. We believe he is the right person to lead Progenity into this next phase of growth as we advance the discovery, development, and delivery of therapeutics.” “Progenity’s innovative platforms show substantial promise to...

Continue reading

NGM Bio to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (NGM) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, will present an overview of the company and provide a business update at the following upcoming 2021 virtual investor conferences: Stifel 2021 Virtual Healthcare Conference Monday, November 15, 2021, 2:40pm ET Jefferies London Healthcare Conference Thursday-Friday, November 18-19, 2021; presentation available on-demand beginning November 18, 2021, 3:00am ET 33rd Annual Piper Sandler Healthcare ConferenceTuesday-Thursday, November 30-December 2, 2021; presentation available on-demand beginning November 22, 2021, 10:00am ET Evercore ISI Healthcare...

Continue reading

Check Point Software Launches Mind to Make Cybersecurity Knowledge and Skills Accessible to All

With programs from over 200 global training partners, the portal is a platform for users to learn from the masters of the industry to address the global cybersecurity skills shortage SAN CARLOS, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, is launching today Check Point Mind, a knowledge training portal, in collaboration with over 200 of the world’s most recognized training partners. Users can sign up with the portal or free, and choose from a wide range of courses and programs available from over 200 partners. Payment can be made through credit card or Check Point Learning Credits. In August 2021, US president Joe Biden met with leading technology firms to discuss cybersecurity issues, including the need to hire and train...

Continue reading

Fanhua to Announce Third Quarter 2021 Unaudited Financial Results and Host Conference Call on November 23, 2021

GUANGZHOU, China, Nov. 09, 2021 (GLOBE NEWSWIRE) — Fanhua Inc. (“Fanhua” or “the Company”) (Nasdaq: FANH), a leading independent financial services provider in China, today announced that it will release its unaudited financial results for third quarter 2021 after the close of the U.S. financial markets on November 23, 2021. Mr. Chunlin Wang, chairman & CEO and Mr. Peng Ge, CFO will host a conference call to discuss third quarter 2021 financial results at: Time: 8:00 p.m. Eastern Time on November 23, 2021    or 9:00 a.m. Beijing Time on November 24, 2021 The toll free dial-in numbers:United States 1-833-239-5565United Kingdom 0800-279-8057France 0805-101-226Germany  0800-182-0671Australia   1-300-717-205Hong Kong, China 800-906-601Japan 0120-925-376South Korea  080-850-0474   The toll dial-in...

Continue reading

Atotech Reports Third Quarter 2021 Results and Narrows 2021 Full-Year Guidance Range

Generates third quarter revenue of $383 million, an increase of 18% over the prior-year period, including chemistry organic revenue growth of 6% Reports net income of $19 million, an increase of 75% compared to Q3 2020 Delivers Adjusted EBITDA of $112 million, a 10% increase over the prior-year period Net leverage decreased to 3.1x Confirms guidance for full year 2021 organic revenue growth, which is expected to be in the range of 13% to 14%, including full year chemistry organic revenue growth of approximately 10% Narrows guidance for full year 2021 Adjusted EBITDA1, which is anticipated to be in the range of $440 million to $450 million.BERLIN, Germany, Nov. 09, 2021 (GLOBE NEWSWIRE) —  Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, today reported...

Continue reading

Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

Reported updated data from the UpRi ovarian cancer expansion cohort further bolstering confidence in UPLIFT registration strategy Introduced UP-NEXT, a Phase 3 study of UpRi monotherapy maintenance in platinum-sensitive ovarian cancer Presented preclinical data for XMT-2056, a HER2-targeted Immunosynthen STING-agonist ADC, demonstrating robust activity and broad combination potential Ended third quarter with approximately $192 million in cash and equivalents; strengthened financial flexibility with new credit facility of up to $100 millionCAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today reported financial...

Continue reading

Texas Mineral Resources Signs Mineral Exploration and Option Agreement with Santa Fe Gold to Jointly Explore and Develop a Target Silver Property Within the Black Hawk Mining District in New Mexico

SIERRA BLANCA, TX, Nov. 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Texas Mineral Resources Corp. (OTCQB: TMRC): ·         Non-dilutive funding established to fund bankable feasibility study ·         Initial target silver property has been selected by TMRC within the Black Hawk Mining District among patented and unpatented claims held by Santa Fe Gold ·         Geology generally characterized by narrow ultra-high-grade silver veins ·         Bankable feasibility study to be conducted in measured phases to minimize financial risk ·         TMRC establishes new Standard Silver subsidiary to hold silver project assets Texas Mineral Resources Corp. (TMRC), an exploration company currently targeting the heavy rare earths, technology metals and a variety of industrial minerals primarily through its joint-venture Round Top Mountain...

Continue reading

Rubicon Organics Provides Operational Update

Simply Bare™ Organic becomes the #1 premium flower and pre-roll brand in Canada Rubicon Organics increased its market share in the Canadian flower and pre-roll category to 2.2% for the three months ended October 31, 2021VANCOUVER, British Columbia, Nov. 09, 2021 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to provide an operational update for the period ending October 31, 2021. Management Commentary “We are quickly climbing the ranks in total market share across Canada and have established Simply Bare™ Organic as the leading premium flower and pre-roll brand. This reflects our steadfast commitment to product quality and the broader availability of a...

Continue reading

REPEAT – Prospect Ridge Resources Announces Knauss Creek Property Option Agreement Including the Dorreen Mine, With Historical Production Grades Averaging 57 Grams Per Tonne of Gold & 205.71 Grams Per Tonne Silver

Figure 1Figure 1 – Knauss Creek Property LocationFigure 2Figure 2 – Mineral Occurrences at the Knauss Creek PropertyFigure 3Figure 3 – Photos of the Dorreen VeinVANCOUVER, British Columbia, Nov. 09, 2021 (GLOBE NEWSWIRE) — Prospect Ridge Resources Corp. (the “Company” or “Prospect Ridge“) (CSE: PRR) (OTC: PRRSF) is pleased to announce that it has entered into a property option agreement with Knauss Creek Mines Ltd. (the “Optionor”) dated November 3, 2021 (the “Agreement“), pursuant to which the Company has acquired an option (the “Option”) to purchase a 100% interest in a single block of 35 mineral claims covering approximately 3,152.2 hectares collectively known as the Knauss Creek Property (the “Property”). Prospect Ridge’s Holy Grail holdings...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.